LEVETIRACETAM- levetiracetam tablet, film coated

Ország: Egyesült Államok

Nyelv: angol

Forrás: NLM (National Library of Medicine)

Aktív összetevők:

LEVETIRACETAM (UNII: 44YRR34555) (LEVETIRACETAM - UNII:44YRR34555)

Beszerezhető a:

Lake Eire Medical & Surgical Supply DBA Quality Care Products LLC

INN (nemzetközi neve):

LEVETIRACETAM

Összetétel:

LEVETIRACETAM 750 mg

Az alkalmazás módja:

ORAL

Recept típusa:

PRESCRIPTION DRUG

Terápiás javallatok:

Levetiracetam tablets are indicated as adjunctive therapy in the treatment of partial onset seizures in adults and children 4 years of age and older with epilepsy. This product should not be administered to patients who have previously exhibited hypersensitivity to levetiracetam or any of the inactive ingredients in levetiracetam tablets. The abuse and dependence potential of levetiracetam has not been evaluated in human studies.

Termék összefoglaló:

Levetiracetam tablets, 250 mg are blue coloured, oblong-shaped, biconvex, film-coated tablets debossed with "L" and “U” on either side of the breakline on one side and “X01” on the other side. They are supplied in containers of 90 tablets (NDC 68180-112-09), 120 tablets (NDC 68180-112-16) and 500 tablets (NDC 68180-112-02). Levetiracetam tablets, 500 mg are yellow coloured, oblong-shaped, biconvex, film-coated tablets debossed with "L" and “U” on either side of the breakline on one side and “X02” on the other side. They are supplied in containers of 90 tablets (NDC 68180-113-09), 120 tablets (NDC 68180-113-16) and 500 tablets (NDC 68180-113-02). Levetiracetam tablets, 750 mg are orange coloured, oblong-shaped, biconvex, film-coated tablets debossed with "L" and “U” on either side of the breakline on one side and “X03” on the other side. They are supplied in containers of 90 tablets (NDC 68180-114-09), 120 tablets (NDC 68180-114-16) and 500 tablets (NDC 68180-114-02). Store at 25°C (77°F); excursions permitted to 15° - 30°C (59°-86°F). [See USP Controlled Room Temperature] Pharmacist: Dispense in a tight, light-resistant container with a child-resistant closure along with medication guide provided separately. Manufactured for Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 United States Manufactured by Lupin Limited Mumbai 400 098 INDIA Revised: 1st May 2010                                                            ID #: 221659

Engedélyezési státusz:

Abbreviated New Drug Application

Betegtájékoztató

Lake Eire Medical & Surgical Supply DBA Quality Care Products LLC
----------
MEDICATION GUIDE
LEVETIRACETAM TABLETS
250 mg, 500 mg and 750 mg tablets
Read this Medication Guide before you start taking LEVETIRACETAM
TABLETS and each time you
get a refill. There may be new information. This information does not
take the place of talking to your
healthcare provider about your medical condition or treatment.
What is the most important information I should know about
LEVETIRACETAM TABLETS?
Like other antiepileptic drugs, LEVETIRACETAM TABLETS may cause
suicidal thoughts or
actions in a very small number of people, about 1 in 500 people taking
it.
Call a healthcare provider right away if you have any of these
symptoms, especially if they are new,
worse, or worry you:
•
thoughts about suicide or dying
•
attempts to commit suicide
•
new or worse depression
•
new or worse anxiety
•
feeling agitated or restless
•
panic attacks
•
trouble sleeping (insomnia)
•
new or worse irritability
•
acting aggressive, being angry, or violent
•
acting on dangerous impulses
•
an extreme increase in activity and talking (mania)
•
other unusual changes in behavior or mood
Do not stop LEVETIRACETAM TABLETS without first talking to a
healthcare provider.
•
Stopping LEVETIRACETAM TABLETS suddenly can cause serious problems.
Stopping a
seizure medicine suddenly can cause seizures that will not stop
(status epilepticus).
•
Suicidal thoughts or actions can be caused by things other than
medicines. If you have suicidal
thoughts or actions, your healthcare provider may check for other
causes.
How can I watch for early symptoms of suicidal thoughts and actions?
•
Pay attention to any changes, especially sudden changes, in mood,
behaviors, thoughts, or
feelings.
•
Keep all follow-up visits with your healthcare provider as scheduled.
•
Call your healthcare provider between visits as needed, especially if
you are worried about
symptoms.
What is LEVETIRACETAM TABLET?
LEVETIRACETAM TABLET is a prescription medicine taken

Termékjellemzők

LEVETIRACETAM- LEVETIRACETAM TABLET, FILM COATED
LAKE EIRE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC
----------
LEVETIRACETAM TABLETS
250 MG, 500 MG AND 750 MG
RX ONLY
DESCRIPTION
Levetiracetam is an antiepileptic drug available as 250 mg (blue), 500
mg (yellow) and 750 mg (orange)
tablets.
The chemical name of levetiracetam, a single enantiomer, is
(-)-(S)-α-ethyl-2-oxo-1-pyrrolidine
acetamide, its molecular formula is C H N O and its molecular weight
is 170.21. Levetiracetam is
chemically unrelated to existing antiepileptic drugs (AEDs). It has
the following structural formula:
Levetiracetam is a white to off-white crystalline powder with a faint
odor and a bitter taste. It is very
soluble in water (104.0 g/100 mL). It is freely soluble in chloroform
(65.3 g/100 mL) and in methanol
(53.6 g/100 mL), soluble in ethanol (16.5 g/100 mL), sparingly soluble
in acetonitrile (5.7 g/100 mL)
and practically insoluble in n-hexane. (Solubility limits are
expressed as g/100 mL solvent.)
Levetiracetam tablets contain the labeled amount of levetiracetam.
Inactive ingredients: colloidal silicon
dioxide, corn starch, microcrystalline cellulose, crospovidone,
hypromellose, magnesium stearate,
povidone, polyethylene glycol, polyvinyl alcohol, talc, titanium
dioxide, and additional agents listed
below:
250 mg tablets: FD&C Blue #2 aluminium lake
500 mg tablets: Yellow Iron Oxide
750 mg tablets:FD&C Blue #2 aluminium lake, FD&C Yellow #6 aluminium
lake, Iron Oxide Red
CLINICAL PHARMACOLOGY
MECHANISM OF ACTION
The precise mechanism(s) by which levetiracetam exerts its
antiepileptic effect is unknown. The
antiepileptic activity of levetiracetam was assessed in a number of
animal models of epileptic seizures.
Levetiracetam did not inhibit single seizures induced by maximal
stimulation with electrical current or
different chemoconvulsants and showed only minimal activity in
submaximal stimulation and in threshold
tests. Protection was observed, however, against secondarily
generalized activity from focal seizures
induced